Login / Signup

Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab.

Maya Srikanth GrahamSimone KrebsTejus BaleKwaku DomfeStephanie M LobaughZhigang ZhangMark P DunphyThomas KaleyRobert J Young
Published in: Neuro-oncology advances (2020)
FDG PET is a promising imaging tool to further stratify prognosis in recurrent GBM patients on antiangiogenic therapy.
Keyphrases
  • positron emission tomography
  • computed tomography
  • pet ct
  • pet imaging
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • stem cells
  • peritoneal dialysis
  • metastatic colorectal cancer